Skip to main content

Peer Review reports

From: Treatment patterns for patients initiating novel acute migraine specific medications (nAMSMs) in the context of monoclonal antibodies (mAbs) targeting the calcitonin gene-related peptide (CGRP) pathway

Original Submission
15 Sep 2023 Submitted Original manuscript
25 Sep 2023 Reviewed Reviewer Report
25 Sep 2023 Reviewed Reviewer Report - Eleonora de Matteis
6 Oct 2023 Author responded Author comments - Robert Urman
9 Oct 2023 Author responded Author comments - Robert Urman
Resubmission - Version 2
6 Oct 2023 Submitted Manuscript version 2
Publishing
10 Oct 2023 Editorially accepted
9 Nov 2023 Article published 10.1186/s10194-023-01678-y

You can find further information about peer review here.

Back to article page

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us